Put Warnings About Liver Damage With Hep C Meds Into Perspective

April 2017

You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.

FDA now requires a boxed warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.

And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Infectious Diseases Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections
Surgery Help Optimize Peri-Op Antifibrinolytic Use to Reduce Blood Transfusions
Nephrology Lean Toward Trying Urea Before "Vaptans" for Hyponatremia
Heart Failure Focus on BP Control in Heart Failure Patients With Preserved Ejection Fraction
Fall Risk Be Sure Your Facility Uses a Fall-Risk Medication Assessment
New Drugs Don't Expect the Constipation Med Plecanatide (Trulance) to Be on Your Formulary
Neurology Pain Ask Patients on Pramipexole or Ropinirole About Worsening Restless Legs Syndrome
Antithrombotics Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets
Constipation Help Parents With Concerns About Miralax and Neuropsych Effects in Children
Topicals Help Prescribers Choose Between Different Topical Dosage Forms
Neuromuscular Start With Baclofen or Gabapentin for Persistent Hiccups
Hepatitis C Put Warnings About Liver Damage With Hep C Meds Into Perspective